E. Williamson

First name
E.
Last name
Williamson
Herrett, E., Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., et al. (2019). Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study. Lancet. http://doi.org/10.1016/s0140-6736(19)31359-5
Sinnott, S. J., Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., & Douglas, I. J. (2019). The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4808
Hopkins, C., Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., et al. (2019). Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records. Rhinology. http://doi.org/10.4193/Rhin19.136
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2020). Real world effects of COPD medications: a cohort study with validation against RCT results. Eur Respir J. http://doi.org/10.1183/13993003.01586-2020
Tazare, J., Smeeth, L., Evans, S. J. W., Williamson, E., & Douglas, I. J. (2020). Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5121
Wilkinson, S., Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., et al. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2021). Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health Technol Assess. http://doi.org/10.3310/hta25510
Brown, J. P., Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., et al. (2021). Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14728